Skip to main content
Search

Henan Cancer Hospital

2 related articles

Subscribe to updates
  1. Clinical Implementation and Evaluation of an Artificial Intelligence-Driven One-Click Automatic Planning System for Functional Lung Avoidance Radiotherapy

    This study implemented AP-FLART, which integrates dosimetric score-based beam angle selection, multi-modality-guided dose prediction, and function-guided dose mimicking, within RayStation and evaluated it on a test dataset of 33 lung cancer patients who underwent SPECT ventilation or perfusion imaging and lung radiotherapy, finding that automatic FLART plans significantly reduced high-function lung mean dose by 15.1% versus manual conventional radiotherapy plans, lowered the probability of grade >=2 radiation pneumonitis by 6.25 percentage points (27%) among FLART-benefiting patients, achieved clinical benefits similar to manual FLART plans, were clinically acceptable without modification in 87.9% of cases, and cut planning time from 2-3 hours to approximately 8 minutes.

  2. Multimodal AI and single-cell transcriptomics integrate to construct a histopathological prognostic model for bladder cancer, revealing the RTN3-glycolysis axis in chemoresistance

    This study integrated six public single-cell RNA sequencing datasets, used inferCNV to infer copy number variations at the single-cell level and identify a high-CNV (HCNV) malignant subpopulation, built a multimodal deep-learning AI prognostic model on routine H&E-stained sections with HCNV activity as the biological anchor for pathology feature selection, and through multiomics screening plus in vitro and in vivo experiments identified RTN3 as the core driver gene, showing that RTN3 activates JAK2/STAT3 to transcriptionally upregulate glycolytic enzymes PKM2, GLUT1 and LDHA, driving glycolytic metabolic reprogramming and conferring gemcitabine resistance in bladder cancer.

You’re all caught up